© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Long before glass ampoules and prefilled syringes, atropine held a reputation in European folk medicine. Dating back to the use of deadly nightshade, or Atropa belladonna, the active alkaloid that now bears the name “atropine” saw plenty of dubious experiments. Italian women dropped belladonna juice into their eyes, chasing beauty by dilating their pupils. By the early 1800s, Pierre Robiquet isolated atropine, pushing the compound from folklore to pharmacy. Pharmacologists then raced to purify, crystallize, and stabilize atropine, making it safe for controlled dosing. Later, compounding chemists produced its sulfate salt, enhancing solubility and shelf life. Hospitals gradually standardized the monohydrate form for intravenous use, which enabled wider and more predictable treatment across a growing range of indications.
Atropine sulfate monohydrate no longer stays just in military field kits or Victorian glass bottles. Today, you’ll find it in sterile injectables, ophthalmic drops, and research labs. The sulfate monohydrate form means a single water molecule clings to each unit, improving stability during transit and storage. Each batch arrives as a white, odorless crystalline powder, weighed and packaged to strict protocols. Dosing requires accuracy, since atropine isn’t forgiving when errors happen. Every vial, syringe, or bottle of solution targets a precise clinical need—whether it’s reversing dangerous bradycardia, pre-empting anesthetic complications, or treating pesticide poisoning. Manufacturers work under tight guidelines, knowing lives hinge on every microgram.
Atropine sulfate monohydrate forms fine, white crystals, barely soluble in alcohol but highly soluble in water. Each molecule has a unique structure: a tropane ring, an ester linkage, and a benzene component. The molecular weight runs around 694.83 g/mol for the salt with water, a figure factored into every calculation on the dosing floor. It tastes bitter, irritating the tongue upon accidental sampling. Stable at room temperature, it degrades only with excessive heat or under strong acids and bases. Unlike loose alkaloids or base forms, the monohydrate keeps impurities in check, reducing batch-to-batch variability.
Every bottle, vial, or ampoule of atropine sulfate monohydrate must display clear labeling—batch number, strength, expiration date, and precise chemical composition. Pharmacopeia standards shape what goes on paper and plastic: purity, pH limits, and allowed levels of residual solvents. Sterility takes priority, as does clarity in solution. Hospitals rely on these specifications to prevent tragic mix-ups. Regulatory agencies, especially the FDA and EMA, demand proof of stability studies, validated analytical methods, and contamination control. In my experience working with pharmacy operations, a single unreadable or missing label means destroying an entire box to avoid potentially fatal consequences downstream in patient care.
Modern production of atropine sulfate monohydrate begins with extraction from Atropa belladonna or Datura stramonium. The crude alkaloid extract undergoes liquid-liquid separation, followed by reaction with dilute sulfuric acid. This step creates the sulfate salt. Recrystallization from water, sometimes with ethanol washing, generates the monohydrate crystals. Skilled technicians filter and dry the product under vacuum, always watching for degradation. Quality control tests every batch using HPLC or thin-layer chromatography. In my time shadowing at a pharmaceutical plant, the physical labor involved in extraction and purification still surprised me, despite our technological advances. Safety standards protect workers from exposure and accidental poisoning.
The chemistry of atropine traces back to its ester group. Hydrolysis converts atropine to tropine and tropic acid, a process relevant both in lab tests and inside the human body during metabolism. Chemical modification leads to analogues—homatropine, scopolamine—changing potency, side effects, and duration. Sulfate salt formation increases hydrophilicity, useful for intravenous delivery. Pharmaceutical researchers analyze these reactions for clues, pursuing compounds that reduce adverse effects or suit alternative delivery routes. New attempts at synthesizing atropine via greener methods cut reliance on toxic solvents. Each small tweak ripples into the supply chain, regulatory burden, and patient safety.
Atropine sulfate monohydrate travels under several trade names and synonyms. Medical texts reference “atropinum sulfuricum monohydricum,” “atropina sulfato monohidratada,” and “belladonna sulfate.” Pharmaceuticals sell as Atropen, AtroPen Auto-Injector, or just plain Atropine Sulfate Injection. Scientists may tag it by its CAS number in journal articles. Each name signals a promise: the precise arrangement of atoms, the attached water, the strict compliance with pharmacopoeial texts. Clarity in product naming reduces the relentless confusion that arises between pharmacy, nursing station, and emergency code cart.
Handling atropine sulfate monohydrate demands respect—the margin between therapeutic effect and harm remains razor-thin. National and international standards set the rhythms of storage, reconstitution, and disposal. OSHA mandates closed systems in compounding labs. Strict inventory and waste protocols limit environmental release or theft. Only licensed professionals dispense, and all vials require double-checks before patient administration. Every adverse report gets investigated, whether the harm arises from overdose, storage mishap, or labeling error. Emergency personnel train with saline stand-ins to avoid mistakes in the field. Within the hospital, educational updates keep fresh the lessons of past near-misses.
Few drugs touch as many corners of medicine as atropine. Anesthesiology teams draw it up for bradycardia or vagal reflexes; ophthalmologists prepare drops for pupil dilation or uveitis management. Toxicologists call it lifesaving in organophosphate and nerve agent poisoning, while cardiologists value its rapid reversal of certain arrhythmias. Military packs carry auto-injectors, protecting troops in chemical warfare zones. Veterinary practice leans on atropine for similar emergencies in animals. The medical literature overflows with case reports where atropine tips the scale toward life. Access, timely use, and error-free dosing matter most in these scenarios.
Atropine attracts ongoing research for better drug delivery systems, new indications, and deeper understanding of its interactions. Pharmaceutical companies explore sustained-release formulations and minimize systemic side effects. Chemists hunt for derivatives that retain the beneficial antimuscarinic effects but drop the mental confusion and tachycardia. Research partners investigate combinations with other antidotes to improve outcomes in poisoning. Funding organizations support networked registries collecting real-world use and outcomes. As computer modeling grows powerful, virtual screening guides which modifications might perform better in preclinical tests, saving chemists time and resources.
Toxicologists have mapped atropine’s danger to every system in the body. Overdose creates dry mouth, hallucinations, fever, rapid heartbeat, and in severe cases, coma or fatal arrhythmia. Animal studies shape safe starting doses, rescue protocols, and warning labels. Poison control centers rely on these findings to advise hospitals, EMS, and families. These days, researchers explore the subtler impacts of chronic exposure and the risks in populations with comorbidities. Every update changes how clinicians think about dosing for the frail, the very young, or the multi-morbid. From my own reading of post-marketing surveillance and adverse event databases, mistakes still happen—but every tragedy reshapes training and manufacturing safeguards.
Atropine sulfate monohydrate, centuries after its discovery, continues to evolve. As global tensions raise fears of chemical weapon use, atropine’s role as an antidote grows more urgent. Biomedical engineers experiment with transdermal patches and nanocarrier-loaded injectables. The opioid crisis revives interest in multi-antidote platforms, putting atropine together with naloxone for rapid field deployment. Digitization of pharmacy supply chains promises fewer stock-outs and counterfeits. Synthetic biology teams wonder if gene-edited plants could yield purer, steadier supplies. Every gain in safety and delivery traces back to the gritty history of poisoning, warfare, and medical rescue, reminding anyone working with atropine that behind every sterile vial lies a blend of risk, necessity, and hard-earned knowledge.
If you’ve ever watched a medical drama, you might have heard someone shouting for “atropine.” That’s not just TV magic. Atropine sulfate monohydrate stands as a staple in emergency rooms and ambulances around the world. Hospitals keep it close because of its ability to reverse dangerous slow heart rhythms, known as bradycardia. When someone’s heart rate drops dangerously low, every second counts. Administering atropine can save lives by quickly raising the heart rate and improving blood flow.
I’ve seen the serious faces of paramedics as they pull it from their crash kit. They know the risks of waiting too long. A slow heart can mean fainting, seizures, or permanent damage. Atropine acts fast and gives doctors precious time, especially in cardiac arrest situations where time is everything.
Beyond the ER, atropine’s fame comes from its use against nerve agent poisoning. This isn’t just theory; it’s the real deal in disaster medicine. Soldiers and first responders carry atropine auto-injectors because exposure to certain chemicals, like those used in chemical warfare, can cause the body’s nerves to go haywire. Victims start to drool uncontrollably, choke, and lose control of their muscles. Injections of atropine block those deadly effects.
History gives us painful lessons, like the Tokyo subway sarin attack in 1995. Medical teams on the ground used atropine to save lives, turning a chemical weapon’s chaos into something doctors could fight.
Surgery is another field where atropine makes a difference. Before anesthesia, doctors sometimes use it to keep patients’ airways clear. Anesthesia often triggers the body to flood the throat and lungs with secretions. Atropine dries those up, making intubation safer and reducing the risk of complications during and after surgery.
Atropine finds a place in eye clinics, too. Eye doctors might use small doses to dilate pupils during exams. This helps them see the inner structures more clearly. For kids with certain eye problems, atropine drops can slow the worsening of nearsightedness. That’s a major plus for kids facing a lifetime of thick glasses.
Like anything in medicine, atropine’s power doesn’t come without risk. High doses or careless use can trigger dry mouth, confusion, and even hallucinations. Older people with glaucoma or prostate problems face higher dangers. Mistakes in dosing can cause real harm, so professionals must track doses closely.
Healthcare teams work hard to minimize these side effects. Training, strict protocols, and smart monitoring all play a part. Electronic health records flag allergies and risky interactions, while pharmacy oversight reduces the chance for dosing errors.
Atropine’s spot on hospital crash carts is no accident. Stockouts can put lives at risk. Governments and healthcare organizations stay vigilant by stockpiling atropine and training staff in its use. In communities where chemical industry accidents are possible, first responders coordinate with hospitals to keep enough atropine nearby—no room for shortcuts.
Reliable supply and smart training keep this life-saving drug ready for action. Atropine sulfate monohydrate belongs in every serious emergency response plan, whether you’re battling a slow heart or a national crisis.Atropine sulfate monohydrate has a big reputation in healthcare. Doctors use it for a range of issues, like treating slow heart rates or drying up secretions before surgery. Its usefulness makes it a staple in emergency kits and operating rooms. Anyone prescribed this drug deserves clear information about what to expect, not just a list of technical terms. I’ve witnessed hospital staff walk patients and families through potential reactions, and those conversations can ease worry and make for safer care. Picking up this habit outside clinics, by knowing what to watch for, builds both awareness and trust.
People often notice a dry mouth pretty quickly. Thirst may follow. Sometimes the tongue feels thick, which can frustrate anyone needing to talk or eat. A dry mouth might sound harmless, but over days, lack of saliva can lead to trouble with swallowing or even tooth problems. Eyes may react, too—blurred vision and trouble focusing are no surprise, since atropine stops muscles in the eye from tightening as they should. Bright lights suddenly feel harsh. Many wonder if these reactions mean something's wrong. Usually, they don’t signal danger, but older adults may struggle with increased confusion or agitated moods, which families sometimes mistake for delirium caused by age instead of medication.
Once in a while, the drug’s drying effect goes a step further and cuts off sweating. This can drive up body temperature, especially in hot weather or during heavy activity. Heat stroke creeps up quickly, mostly because the body can’t cool itself. Feeling flushed, with red cheeks and skin that stays hot to the touch, offers an early warning sign. Dizziness and rapid heartbeat sometimes follow substantial fluid loss, though not everyone connects these dots to their medicine. I've seen patients try to brush off such symptoms, chalking them up to nerves or poor sleep. A quick check-in with a nurse or doctor often makes all the difference before things spiral.
One frustration with atropine treatments is how it can trigger constipation. For patients with ongoing bowel issues, this risk grows. Stomach pain or bloating may build up—sometimes those with long-term prescriptions keep a log just to make sure nothing gets missed in the shuffle. Occasionally, the medicine pushes into more serious territory by triggering urinary retention. Men with prostate problems feel this shift first, finding it tough to empty their bladders. It can lead to a painful trip to the emergency room if ignored for too long.
Other side effects can touch the heart. Fast, pounding heartbeats—known as tachycardia—pose extra concern for anyone with heart conditions. Doctors tend to watch closely or adjust the dose if this symptom shows up. Some rare issues like allergic reactions do happen, with rashes, tightening throat, or swelling. These require immediate attention, and families need guidance to recognize the signs quickly.
Managing side effects takes teamwork. Patients should speak up about anything unexpected—no detail is too small. Pharmacists help by double-checking other prescriptions for possible interactions. Hydration goes a long way toward feeling better, especially if dry mouth, thirst, or fever sets in. People coping with vision changes prepare by keeping sunglasses handy and avoiding night driving. For those facing constipation, more fiber and movement make a difference, though doctors sometimes recommend a gentle laxative. Heat and activity tolerance drops under this drug, so staying cool and resting more often helps prevent bigger problems. Open conversation helps families, too, by catching problems before they get worse.
Every person’s body handles drugs in a slightly different way, so listening to changes and sharing them early makes treatment much safer. What works for one person may need a tweak for someone else, and experienced healthcare teams rely on clear, honest feedback to get there.
Atropine sulfate monohydrate often comes up in discussion during emergencies – like when a heart slows down or someone has gotten into a toxic chemical. It is a medication hospitals and ambulances keep close. Giving this drug isn’t as simple as handing out antibiotics or painkillers. It calls for medical training and a steady hand. I remember a friend on an emergency crew once commenting that every team member memorizes the process, because hesitation can carry real consequences.
The most direct way doctors introduce atropine sulfate monohydrate into the body is through intravenous injection. This means a healthcare professional finds a vein and delivers the medication straight into the bloodstream. That makes sense, considering many emergencies call for a quick response. Paramedics sometimes use intramuscular injections if starting an IV takes too long, especially once muscles begin to stiffen from certain poisonings. There’s also subcutaneous injection – right under the skin – but that isn’t ideal if someone needs fast action.
Dosing isn’t guesswork. Medical teams calculate dose by age and weight, because too much atropine brings its own risks. In children, the guidelines are tighter. The World Health Organization and U.S. poison control resources suggest a typical adult dose of 0.5 to 1 mg for slow heart rhythms, repeating every few minutes, keeping a close eye on patient response. Going above a safe threshold because someone panics can lead to confusion, rapid heartbeat, and in severe cases, life-threatening arrhythmias.
Some medicines work safely from the comfort of home. Atropine sulfate monohydrate is not one of them. The impact on the heart, pupils, gut, and nervous system can be sharp. Monitoring equipment lets trained personnel spot trouble early. For example, pupils often get wider and dry mouth develops soon after use – classic signs the drug is circulating. In overdose cases like insecticide poisoning with organophosphates, atropine sometimes becomes a life-saving agent. Medical teams push the dose higher until symptoms improve. Watching for side effects, especially in vulnerable folks with preexisting heart problems, stays a top priority.
With news of medication errors still hitting headlines, it’s hard not to think about all the steps involved in getting things right. Hospitals use color-coded labels and double-checks on atropine vials. Some clinics run drills, practicing quick preparation and administration. Layers of training and safeguards do more than slow things down; they catch slips before they land in a patient’s bloodstream. Looking at other countries with strong safety records, investment in ongoing staff education makes a visible difference.
I’ve talked with rural healthcare providers who keep a small stock of atropine sulfate monohydrate despite tight supplies. They share stories about having to improvise if a pharmacy runs low. Addressing shortages, building reliable supply chains, and supporting quick training in rural areas all help create a stronger safety net. The value of fast, correct administration shows with every saved life.
Medications provide relief and treatment for a wide range of conditions, but no single drug suits every person and every situation. Atropine Sulfate Monohydrate often shows up in hospitals, ambulances, and clinics. It helps in slowing nerve signals in the body, which proves critical during bradycardia, organophosphate poisoning, or preoperative care. A clear grasp of contraindications can make the difference between safe treatment and severe complications.
Doctors avoid this medication in certain circumstances. Narrow-angle glaucoma stands out as a major red flag. Atropine raises intraocular pressure, which pushes a glaucoma patient dangerously close to further vision loss. This warning isn't just written in textbooks—I remember a case during clinical rounds where simple pupil dilation medication triggered a pressure spike for a patient who didn’t even realize they had glaucoma.
People battling myasthenia gravis also face extra danger. Atropine blocks acetylcholine, the very substance these patients desperately need to strengthen nerve signals. While pyridostigmine helps myasthenia gravis, adding atropine works against that purpose. Having witnessed a patient with muscle weakness worsen after an administrative mix-up, it’s clear that cross-checking neuroactive drugs becomes life-saving.
Sometimes, people struggle with untreated obstructive diseases of the gut, like paralytic ileus or enlarged prostate (benign prostatic hyperplasia). Atropine’s anticholinergic effects slow motility further or make urination impossible. Someone with trouble urinating deals with setbacks and emergencies if atropine enters the mix. In the emergency room, I’ve seen confusion over drug allergies turn a routine scan into a urinary crisis.
Here’s another aspect that rarely gets attention: individuals with heart conditions. While atropine helps jump-start a dangerously slow heart, improper use in unstable cardiac situations—like certain heart block types—introduces risks. Ventricular arrhythmias or unstable tachycardia don’t improve with atropine, and actually may worsen.
Children, especially infants, require careful calculation of dosage and frequent monitoring. They’re more sensitive to anticholinergic effects, which show up as flushed skin, fever, agitation, or even seizures. Taking care of a feverish, floppy infant who accidentally swallowed medication drove home the need for parental education and medication safety at home.
Reviewing every prescription and patient history before medications reach the bloodstream sounds simple. In practice, it demands focus and teamwork—a habit of vetting medical records and double-checking lists. Clinicians doing so report far fewer medication errors (source: National Coordinating Council for Medication Error Reporting and Prevention statistics).
Digital health records help spot patterns and contraindications, but communication remains crucial. There’s no replacement for a direct question to the patient about their history, even if a chart doesn’t flag obstructive uropathy or acute glaucoma. Nurse-to-doctor huddles, clear signage for high-risk patients, and quick bedside tests for certain conditions offer practical steps to reduce missteps.
Pharmacists and prescribers keep protocols fresh through continuing education. Hospitals holding regular training sessions reduce dangerous drug interactions and missed contraindications—by nearly 30%, according to the American Society of Health-System Pharmacists. Patient advocacy also matters in preventing errors; when patients understand their risks, they become more likely to mention symptoms or diagnoses others might overlook.
Every clinician needs the discipline to think beyond the symptom on the chart. Knowing that a simple drug like Atropine Sulfate Monohydrate isn’t simple for everyone—because of clear contraindications—protects vision, health, and sometimes life itself.
Anyone who has found themselves in an emergency medicine setting, or seen a child at risk of poisoning, understands the power of medications with narrow dosage windows. Atropine sulfate, a medication found in emergency carts and field medic kits, saves lives during specific types of poisoning, bradycardia, and as a pre-anesthetic agent. The problem is, too little does nothing, too much can bring trouble fast. Knowledge about proper use directly impacts lives, especially when seconds matter.
Dosing for atropine sulfate monohydrate depends on use case and patient age. In adults dealing with bradycardia, authorities like the American Heart Association agree: give 0.5 mg intravenously, repeat every 3–5 minutes. Max out at 3 mg. Give too much too quickly and the heart may go from slow to dangerously fast. For organophosphate or cholinergic poisonings, dosing jumps higher. Start with 2 to 5 mg IV, and repeat every 5 to 10 minutes as needed, watching for symptoms to subside. There’s no hard ceiling in severe poisoning, since the goal is to reverse life-threatening symptoms, not stick to arbitrary rules.
Kids present new challenges. Heart rate and body weight differences force doctors to think differently. Pediatric guidance points to 0.02 mg/kg with a minimum single dose of 0.1 mg, and no more than 0.5 mg per dose. Go above 1 mg in children or 2 mg in adolescents, and side effects swing into view: confusion, flushed skin, blurred vision, trouble speaking.
Working in pediatric emergency rooms taught me to respect how quickly atropine’s effects show up. Parents fear the red cheeks and new agitation, but in a child poisoned by insecticides or with a dangerously slow heart, those early warnings turn into relief. In a single shift, I watched as a lethargic child revived after a measured dose, and then as the team carefully monitored for side effects, ready to step in if the dosage needed adjustment.
Mistakes have consequences. Overdosing can trigger racing heartbeats, overheating, hallucinations, or even collapse. Not enough, the patient continues to seize or the heart refuses to cooperate. Reading the numbers and clinical response, rather than relying on protocol alone, separates safe care from disaster.
Textbooks and guidelines come from years of evidence. The World Health Organization, Centers for Disease Control, and American Heart Association publish specific figures for a good reason. Atropine’s uses sound straightforward, yet everyone—from hospital pharmacist to EMT—benefits from easy-to-read, frequently updated protocols at the bedside. Label syringes clearly. Use double-check systems before pushing a dose. In emergencies, stress and adrenaline push memory aside; a printed chart is worth more than perfect recall.
The healthcare system grows safer when clinical teams share near-misses and errors. Pharmacy teams, nurses, and physicians bridge the gap between textbook and reality by reviewing every event, not sweeping mistakes aside. Educators can build realistic simulation scenarios so trainees learn the physical cues of over- or underdosing.
In my career, those concrete steps—written protocols in hand, conversations at the bedside, teamwork during stressful moments—made the true difference. Information alone saves nobody. Applying the right dose of atropine, at the right time, with everyone on the same page, does.
| Names | |
| Preferred IUPAC name | (1R,3r,5S)-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl) 2-hydroxy-2-phenylacetate sulfate monohydrate |
| Other names |
Atropine sulfate monohydrate Atropine sulfate hydrate Atropine sulfate, monohydrate Atropine sulphate monohydrate |
| Pronunciation | /ˈætrəˌpiːn ˈsʌl.feɪt ˌmɒn.oʊˈhaɪdreɪt/ |
| Identifiers | |
| CAS Number | `5908-99-6` |
| Beilstein Reference | 4092935 |
| ChEBI | CHEBI:3576 |
| ChEMBL | CHEMBL1200713 |
| ChemSpider | 22570170 |
| DrugBank | DB00572 |
| ECHA InfoCard | 34c5af7a-1418-4fa6-987f-3e96050ccf97 |
| EC Number | 220-102-9 |
| Gmelin Reference | 1260809 |
| KEGG | C00533 |
| MeSH | D001260 |
| PubChem CID | 23665706 |
| RTECS number | SY7175000 |
| UNII | QTT17582CB |
| UN number | Not regulated |
| CompTox Dashboard (EPA) | CompTox Dashboard (EPA) of product 'Atropine Sulfate Monohydrate' is "DTXSID7034673 |
| Properties | |
| Chemical formula | (C17H23NO3)2·H2SO4·H2O |
| Molar mass | 695.83 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 0.943 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -2.2 |
| Acidity (pKa) | 14.1 (at 25 °C) |
| Basicity (pKb) | 9.76 |
| Magnetic susceptibility (χ) | -72.0e-6 cm³/mol |
| Dipole moment | 3.09 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 260.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -4671 kJ/mol |
| Pharmacology | |
| ATC code | A03BA01 |
| Hazards | |
| Main hazards | Toxic if swallowed, in contact with skin or if inhaled. Causes serious eye irritation. |
| GHS labelling | GHS05, GHS06, GHS07 |
| Pictograms | GHS06,GHS08 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| Lethal dose or concentration | LD50 Oral Rat 453 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): 150 mg/kg |
| NIOSH | N0137 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 30 µg/m³ |
| Related compounds | |
| Related compounds |
Atropine Atropine sulfate Hyoscyamine Scopolamine Tropine |
